ArticleArchives of toxicology2025
Grouping of chemicals for safety assessment: the importance of toxicokinetic properties of salicylate esters.
Article in Archives of toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
- Erratum issued
Authors and funding
16 authors.
Funding
Abstract
Grouping of chemicals has been proposed as a strategy to speed up the screening and identification of potential substances of concern among the broad chemical universe under REACH. Such grouping is usually based on shared structural features and should only be used for the prioritization objectives. However, additional considerations (as well as structural similarity) are needed, e.g., mode of action, metabolic pathways, chemical reaction products and physicochemical properties, when regulatory management measures are considered (such as restriction, harmonized classification and labeling). Guidance documents from the European Chemicals Agency (ECHA) recommend considering toxicokinetic information to enhance the robustness of the grouping; however, examples of this approach are lacking. Therefore, this paper shares findings on chemical grouping based on ADME data generated for multiple esters of salicylic acid. These differ with respect to chain length and branching of the alcohol moiety of salicylic acid ester, resulting in a wide range of lipophilicity (LogP 0.21-10.88). Since LogP impacts skin absorption, as well as hydrolysis by carboxylesterases, the bioavailability and thus internal exposure to topically applied salicylate esters can vary considerably. Therefore, we collected skin absorption and metabolism data for 41 salicylates using in vitro testing and in silico models and combined the information to group them according to their potential systemic exposure to the major metabolite, salicylic acid. The results show that, despite a similar general chemical structure, their toxicokinetics vary considerably, indicating the need for better understanding of ADME properties to assess the internal exposure for sound risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.